These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

920 related items for PubMed ID: 16841022

  • 1. Insulin detemir (levemir), a new long-acting insulin.
    Med Lett Drugs Ther; 2006 Jul 03; 48(1238):54-5. PubMed ID: 16841022
    [Abstract] [Full Text] [Related]

  • 2. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
    Peterson GE.
    Curr Med Res Opin; 2006 Dec 03; 22(12):2613-9. PubMed ID: 17166343
    [Abstract] [Full Text] [Related]

  • 3. Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes: a double-blind, randomized, crossover study: response to Porcellati et al.
    Banarer S.
    Diabetes Care; 2008 Mar 03; 31(3):e16; author reply e17. PubMed ID: 18308679
    [No Abstract] [Full Text] [Related]

  • 4. Insulin detemir: new drug. A second long-acting insulin analogue: many uncertainties, few advantages.
    Prescrire Int; 2006 Oct 03; 15(85):163-7. PubMed ID: 17121210
    [Abstract] [Full Text] [Related]

  • 5. Insulin glargine: a long-acting insulin for diabetes mellitus.
    Garces K.
    Issues Emerg Health Technol; 2003 Nov 03; (52):1-4. PubMed ID: 14626260
    [Abstract] [Full Text] [Related]

  • 6. Insulin detemir--a new basal insulin analog.
    Goldman-Levine JD, Lee KW.
    Ann Pharmacother; 2005 Mar 03; 39(3):502-7. PubMed ID: 15657117
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Spotlight on insulin detemir in type 1 and 2 diabetes mellitus.
    Chapman TM, Perry CM.
    BioDrugs; 2005 Mar 03; 19(1):67-9. PubMed ID: 15691219
    [Abstract] [Full Text] [Related]

  • 9. Insulin detemir: a new basal insulin analogue.
    Soran H, Younis N.
    Diabetes Obes Metab; 2006 Jan 03; 8(1):26-30. PubMed ID: 16367879
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Insulin detemir. Novo Nordisk.
    Barlocco D.
    Curr Opin Investig Drugs; 2003 Apr 03; 4(4):449-54. PubMed ID: 12808886
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Insulin analogs versus human insulin in type 2 diabetes.
    Migdalis IN.
    Diabetes Res Clin Pract; 2011 Aug 03; 93 Suppl 1():S102-4. PubMed ID: 21864739
    [Abstract] [Full Text] [Related]

  • 18. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B, Muche R, Riegger I, Moritz M, Heinze E, Debatin KM, Wabitsch M, Karges W.
    Clin Ther; 2006 Dec 03; 28(12):2094-101. PubMed ID: 17296465
    [Abstract] [Full Text] [Related]

  • 19. Incidence rates of heart failure, stroke, and acute myocardial infarction among Type 2 diabetic patients using insulin glargine and other insulin.
    Juhaeri J, Gao S, Dai WS.
    Pharmacoepidemiol Drug Saf; 2009 Jun 03; 18(6):497-503. PubMed ID: 19326365
    [Abstract] [Full Text] [Related]

  • 20. Basal insulin analogues in the management of diabetes mellitus: What progress have we made?
    Owens DR, Matfin G, Monnier L.
    Diabetes Metab Res Rev; 2014 Feb 03; 30(2):104-19. PubMed ID: 24026961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.